beta-D-Galactose pentaacetate is a negative regulator of insulin with plasma membrane penetrating ability and can be hydrolyzed by intracellular esterases. beta-D-Galactose pentaacetate inhibits Leucine (HY-N0486)-induced insulin release in Wistar rat islets, potentially preventing excessive insulin release in pathological conditions[1][2][3].
Molekulargewicht:
390.34
Reinheit:
99.86
CAS Nummer:
[4163-60-4]
Formel:
C16H22O11
Target-Kategorie:
Insulin Receptor
Anwendungsbeschreibung:
MCE Product type: Biochemical Assay Reagents
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten